"For convenient access to appointments in The Johns Hopkins Outpatient Center, please park in the McElderry Street Garage."

During the past decade, Johns Hopkins Outpatient Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins Outpatient Center" #1 sponsor was "Johns Hopkins University" with 15 trials, followed by "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 7 trials sponsored, "Cytokinetics" with 2 trials sponsored, "Advanced Accelerator Applications" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Outpatient Center" #1 collaborator was "Duke University" with 1 trials as a collaborator, "Frantz Viral Therapeutics" with 1 trials as a collaborator, "Frantz Viral Therapeutics, LLC" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins Outpatient Center" are "Amyotrophic Lateral Sclerosis" (5 trials), "Breast Cancer" (2 trials), "Acute Lymphoblastic Leukemia (ALL)" (1 trials), "Articular Cartilage Defect" (1 trials) and "Articular Cartilage Disorder of Knee" (1 trials). Many other conditions were trialed in "Johns Hopkins Outpatient Center" in a lesser frequency.

Most popular intervention types in "Johns Hopkins Outpatient Center" are "Drug" (16 trials), "Device" (7 trials), "Other" (6 trials), "Procedure" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Reldesemtiv" (2 trials), "177Lu-DOTA0-Tyr3-Octreotate" (1 trials), "18F-DCFBC" (1 trials) and "18GA Conventional Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins Outpatient Center" are 23 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Johns Hopkins Outpatient Center". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Johns Hopkins Outpatient Center, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins Outpatient Center, 6 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".